SELARL PHARMACIE DES CHUTES LAVIE : revenue, balance sheet and financial ratios

SELARL PHARMACIE DES CHUTES LAVIE is a French company founded 9 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in MARSEILLE (13004), this company of category PME shows in 2018 a revenue of 2.3 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE DES CHUTES LAVIE (SIREN 821181443)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017
Revenue N/C N/C N/C N/C N/C N/C 2 288 248 € 2 267 562 €
Net income 10 180 € 134 875 € 275 018 € 308 009 € 187 208 € 192 556 € 187 576 € 13 226 €
EBITDA N/C N/C N/C N/C N/C N/C 277 939 € 242 814 €
Net margin N/C N/C N/C N/C N/C N/C 8.2% 0.6%

Revenue and income statement

In 2024, SELARL PHARMACIE DES CHUTES LAVIE generates positive net income of 10 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 13 k€ -> 10 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

10 180 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 128%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 39%. The balance between equity and debt is satisfactory.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

127.873%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

39.438%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

90.2%

Solvency indicators evolution
SELARL PHARMACIE DES CHUTES LAVIE

Sector positioning

Debt ratio
127.87 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average +13 pts over 3 years

In 2024, the debt ratio of SELARL PHARMACIE DES CHUT... (127.87) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
39.44% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average -11 pts over 3 years

In 2024, the financial autonomy of SELARL PHARMACIE DES CHUT... (39.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 333.01. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

333.006

Liquidity indicators evolution
SELARL PHARMACIE DES CHUTES LAVIE

Sector positioning

Liquidity ratio
333.01 2024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Excellent

In 2024, the liquidity ratio of SELARL PHARMACIE DES CHUT... (333.01) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELARL PHARMACIE DES CHUTES LAVIE

Positioning of SELARL PHARMACIE DES CHUTES LAVIE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELARL PHARMACIE DES CHUTES LAVIE is estimated at 142 120 € (range 98 970€ - 212 620€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
98k€ 142k€ 212k€
142 120 € Range: 98 970€ - 212 620€
NAF 5 année 2024

Valuation method used

Net Income Multiple
10 180 € × 14.0x = 142 120 €
Range: 98 970€ - 212 620€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE DES CHUTES LAVIE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE DES CHUTES LAVIE

What is the revenue of SELARL PHARMACIE DES CHUTES LAVIE ?

The revenue of SELARL PHARMACIE DES CHUTES LAVIE in 2018 is 2.3 M€.

Is SELARL PHARMACIE DES CHUTES LAVIE profitable?

Yes, SELARL PHARMACIE DES CHUTES LAVIE generated a net profit of 10 k€ in 2024.

Where is the headquarters of SELARL PHARMACIE DES CHUTES LAVIE ?

The headquarters of SELARL PHARMACIE DES CHUTES LAVIE is located in MARSEILLE (13004), in the department Bouches-du-Rhone.

Where to find the tax return of SELARL PHARMACIE DES CHUTES LAVIE ?

The tax return of SELARL PHARMACIE DES CHUTES LAVIE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE DES CHUTES LAVIE operate?

SELARL PHARMACIE DES CHUTES LAVIE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.